Results 251 to 260 of about 17,995 (265)

Late-Onset EBV Susceptibility and Refractory Pure Red Cell Aplasia Revealing DADA2

Journal of Clinical Immunology, 2020
Tom Le Voyer, D. Boutboul, A. Ledoux-Pilon, F. D. de Fontbrune, Guilaine Boursier, S. Latour, G. Le Guenno   +6 more
semanticscholar   +1 more source

Daratumumab for pure red cell aplasia post ABO incompatible allogeneic hematopoietic stem cell transplant for aplastic anemia.

Blood Cells, Molecules & Diseases, 2020
P. Jeyaraman, Pronamee Borah, Priyanka Rajput, N. Dayal, Sangeeta Pathak, R. Naithani   +5 more
semanticscholar   +1 more source

Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
William M Lydiatt, Snehal G Patel, Brian O'Sullivan   +2 more
exaly  

Recent Progress in the Management of Advanced Renal Cell Carcinoma

Ca-A Cancer Journal for Clinicians, 2007
Brian I Rini
exaly  

Refractory Pure Red Cell Aplasia Manifesting as Deficiency of Adenosine Deaminase 2.

Journal of pediatric hematology/oncology, 2017
H. Hashem, R. Egler, J. Dalal
semanticscholar   +1 more source

2016 US lymphoid malignancy statistics by World Health Organization subtypes

Ca-A Cancer Journal for Clinicians, 2016
Lauren R Teras, Carol E Desantis, James R Cerhan   +2 more
exaly  

Current recommendations and recent progress in endometrial cancer

Ca-A Cancer Journal for Clinicians, 2019
Gini F Fleming
exaly  

The role of the microbiome in cancer development and therapy

Ca-A Cancer Journal for Clinicians, 2017
Aadra P Bhatt, Matthew R Redinbo
exaly  

Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant

Journal of clinical apheresis, 2018
K. Sackett, C. Cohn, Kayla Fahey-Ahrndt, Angela R. Smith, Andrew D. Johnson   +4 more
semanticscholar   +1 more source

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly